Merck has formed a strategic discovery pact with Isomorphic Labs to identify small molecule candidates targeting an undisclosed cancer. Isomorphic will leverage its proprietary design engine alongside Merck's lab data, while Merck manages all subsequent preclinical, clinical, and commercialization steps. In a separate regulatory milestone, the FDA approved Sanofi’s Infilbray as the first drug for the neurological aspects of type 3 Gaucher disease. This clearance applies to patients weighing 15 kilograms or more based on clinical trial evidence from 43 stabilized individuals.
Key points
Merck is leveraging computational AI design to accelerate its small molecule oncology dru…: Merck is leveraging computational AI design to accelerate its small molecule oncology drug pipeline.
Infilbray offers the first approved treatment option for the brain and nervous system man…: Infilbray offers the first approved treatment option for the brain and nervous system manifestations of type 3 Gaucher disease.
Sanofi secured federal approval following a late-stage study of 43 patients aged 12 and o…: Sanofi secured federal approval following a late-stage study of 43 patients aged 12 and older with stabilized non-neurological symptoms.
Sources checked by our analysis pipeline: 1
Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. As for the official mascots, they have finished keeping passersby at bay and are now happily snoozing in their respective corners. As for us, we are firing up the trusty kettle for another cup of stimulation. Our choice today is peppermint, an old standby from our pantry. Of course, you are invited to join us. Meanwhile, here is the latest menu of tidbits. As always, do keep in touch. And best of luck today. …
Merck and Isomorphic Labs, the artificial intelligence drug designer built on a Nobel-winning technology that can model how molecules will bind to proteins, are entering into a research collaboration to discover small molecule candidates for an undisclosed oncology target of “strategic importance,” STAT reports. The partnership — only the latest such deal between a pharma giant and Isomorphic — will join Isomorphic’s proprietary drug design engine and existing wet lab…
Formal cross-border planning is essential to safeguard public health across the shared land frontier during major biological threats, according to findings from Dame Heather Hallett's investigation. Early discrepancies in international travel restrictions exposed both jurisdictions to avoidable infection hazards, as seen when travelers from Wuhan moved freely across the island in February 2020. Future emergency protocols must formally align Whitehall's border strategy with Dublin to manage integrated regional heal…
Electronic health record providers face mounting scrutiny over marketplace competition and data interoperability as advanced technologies enter clinical workflows. Epic's latest move addresses these ecosystem pressures while the broader healthcare sector evaluates the operational and regulatory consequences of novel automated tools. The shift coincides with heightened federal oversight and new research tracking the economic footprint of algorithmic clinical tools.
Emergency responders extinguished a workshop blaze on the fifth floor of an industrial facility after a car power pack ignited. The incident triggered explosions beneath a raised vehicle and produced heavy smoke, prompting the hospitalization of two individuals for smoke inhalation. Authorities deployed multiple water jets to control the situation and have launched an inquiry into the failure.